Icon

Mektovi - (15 mg; Tablet)

Binimetinib Array BioPharma
15 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
None
MEKTOVI is a kinase inhibitor indicated, in combination with Encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.
Yes
*** *********** ******* ** *** **, ****. ***** ********* ***** * ****-** ** *** **, ****. ** *** **, **** ******* ****** *** **** ** ***** ******** **** ************ ** * *******, ******** ** ******, *** **** ***** * ****-** ** *** **** *******. **** ***** * ****-** **** ** * ******* ******** ** *** **** *** *** *********. ** ****** **** ***** * **** *** ** *** **** *** **** ****** ****** ****** *** **, ****.
Mektovi Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
******* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
****** *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
**** **** *** **** *** **** *** **** *** *** ********* **** ** *** **, **** **** ** *** **, **** *** ********* **** ** *** **, **** *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** / ********* *** **, **** ******* **** *** ****** *** ****
****** *** / ********* *** **, **** ******* **** *** ****** *** ****
**** *** / ********* -**- ******* ******** ***** *** ****
  1. *** **, **** : * ****-** ** ***** *** ***** *** ***** *** *********.
  2. *** *, **** : **** ******** ***** ***** *** ****-** ****** **** ******* ’***, ’***, *** ’*** *** ******** ** *** **, ****
  3. *** **, **** : ******* ******** ***** ** *** ****-** ****** **** ******* '***, '***, '***, '***, '***, *** '***
  4. *** **, **** : ****** ******** ***** ***** *** ****-** ****** **** ******* '***, '***, '***, '***, '***, *** '***
  5. *** **, **** : ***** **** ******* **** ************ ** ******* '***, '***, '***, '***, '***, *** '***
  6. *** *, **** : ***** **** ****** **** ************ ** ******* '***, '***, '***, '***, '***, *** '***
  7. *** *, **** : ***** **** **** **** ************ ** ******* ’***, ’***, *** ’***

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.